Recruitment completed in trial to evaluate the optimal dosing frequency for Zealand's long-acting GLP-2 analog glepaglutide

World News: . []

- Zealand Pharma LINK  that all subjects have been enrolled and dosed in a LINK  trial with glepaglutide under an investigational new drug application IND for the treatment of short bowel syndrome SBS LINK  p ositive...

More news and information about Zealand Pharma A/S

Published By:

Globe Newswire: 07:37 GMT Tuesday 14th November 2017

Published: .

Search for other references to "recruitment" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us